Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
The Polyurethane Degradation Problem
Polyurethane is a synthetic polymer used by C.R. Bard in the catheter tubing of its PowerPort devices. While polyurethane offers initial flexibility and good biocompatibility, it is fundamentally vulnerable to a degradation process called environmental stress cracking (ESC). ESC occurs when mechanical stress combines with chemical exposure in a biological environment to propagate microscopic cracks through the polymer matrix. Inside the human body, the PowerPort catheter is subjected to relentless mechanical stress from heartbeat-generated pressure waves, respiratory movement, arm and shoulder motion, and arterial pulsation transmitted through surrounding tissue. These forces act on the catheter millions of times per year.
Lipids from surrounding biological tissue are absorbed into the polyurethane polymer. These lipids act as stress-concentrating plasticizers at crack tips, accelerating crack propagation through a phenomenon called lipid-induced stress cracking. Heparin and other flush solutions used to maintain port patency may further degrade the polyurethane surface. Oxidative mechanisms involving metal ions released by metallic port components contribute additional polymer chain scission. The combined result is that over months to years, the catheter wall at high-stress anatomical locations — particularly the clavicle-first rib pinch-off zone — develops progressive cracking until a full-thickness fracture occurs.
Pinch-Off Syndrome: The Mechanical Trigger
The subclavian approach for port catheter placement — used in the majority of PowerPort implantations — routes the catheter through the narrow space between the clavicle and first rib. This anatomical corridor is a mechanical pinch point: every arm elevation, shoulder roll, and deep breath compresses the catheter between these two bony structures. Over time, repetitive compression at this site creates a stress concentration that dramatically accelerates ESC. Radiographic pinch-off is classified on a three-grade scale; Grade III pinch-off — complete catheter occlusion — is strongly associated with catheter fracture and subsequent embolism.
The pinch-off mechanism was documented in the medical literature years before many of the devices currently in litigation were manufactured. Vascular surgeons and interventional radiologists published case series and reviews identifying pinch-off syndrome as a significant hazard of subclavian port placement and polyurethane catheters specifically. This published literature — combined with Bard's internal adverse event reports under 21 CFR Part 803 — establishes that the manufacturer knew or should have known about the fracture risk and failed to take adequate corrective action.
Why Silicone Catheters Do Not Have This Problem
Silicone catheters — used in competing products such as the Hickman catheter and various Mediport devices — do not undergo the same ESC mechanism because silicone polymers have fundamentally different chemical structures that are resistant to lipid-induced stress cracking. Silicone catheters are more flexible and less susceptible to mechanical fatigue fracture in the biological environment. The availability of silicone as a safer design alternative is central to the design defect theory in PowerPort litigation: plaintiffs argue that Bard chose polyurethane over silicone for manufacturing or cost reasons without adequate justification given the known ESC risk, creating a product that was unreasonably dangerous as designed.
Key data
Data & Statistics
Polyurethane ESC documented in medical literature since the 1990s as a known risk of implantable polyurethane catheters
Journal of Biomedical Materials Research
Grade III pinch-off on chest X-ray associated with 4x increased catheter fracture risk vs. Grade 0
Journal of Vascular and Interventional Radiology
PowerPort MDL includes thousands of fracture plaintiffs as of early 2026
MDL 3:22-md-03062 docket, D. Arizona
FAQ
Frequently Asked Questions
Dive deeper
Related Guides
- PowerPort MDL Settlement Timeline — What to ExpectMDL mass tort litigation follows a predictable multi-year progression from case filing through bellwether trials to global settlement. Understanding each phase helps PowerPort plaintiffs set realistic expectations for timing and the factors that determine individual settlement amounts.
- PowerPort Catheter Migration — Where Fragments GoWhen a PowerPort catheter fractures, the free fragment enters the central venous circulation and travels to the heart and lungs following the path of venous blood flow. The fragment's final resting location determines the severity of injury — from retrievable right-heart positions to life-threatening peripheral pulmonary artery lodgment.
- Bard PowerPort MDL in the District of ArizonaMDL No. 3:22-md-03062 in the U.S. District Court for the District of Arizona is the central federal forum for all Bard PowerPort catheter fracture cases. Understanding how the MDL works, where it currently stands, and what participation means for individual plaintiffs is essential for anyone considering a PowerPort lawsuit.
- PowerPort vs. Other Port Catheters — Key DifferencesThe Bard PowerPort's polyurethane catheter is the defining design characteristic that distinguishes it from safer alternatives like Hickman catheters, silicone Mediport devices, and PICC lines — none of which use polyurethane tubing and none of which carry the same environmental stress cracking fracture risk.
- PowerPort Removal Surgery — How Fractured Catheters Are RetrievedRetrieval of a fractured PowerPort catheter fragment requires either percutaneous cardiac catheterization or open thoracic surgery, depending on fragment location and accessibility. The retrieval procedure itself carries procedural risks, and failure to retrieve leaves the patient with an ongoing foreign body infection and cardiac risk.
- PowerPort Sepsis and Infection RiskA fractured PowerPort catheter fragment acts as a permanent intravascular nidus for infection — a foreign body that bacteria colonize with a protective biofilm that antibiotics cannot eradicate without removing the fragment. For immunocompromised cancer patients, this infection risk is particularly life-threatening.
- PowerPort Cardiac Perforation — Heart Surgery RiskCardiac perforation by a fractured PowerPort catheter fragment is a life-threatening emergency. The thin-walled right ventricle is particularly vulnerable to penetration by a fragment's sharp edge, causing cardiac tamponade — a surgical emergency that can be fatal within minutes without treatment.
- Becton Dickinson Liability — BD's Acquisition of BardBecton, Dickinson and Company (BD) acquired C.R. Bard in 2017 for $24 billion and assumed full corporate liability for all Bard product claims, including the PowerPort. BD now faces claims not only for Bard's pre-acquisition conduct but also for BD's own post-acquisition decisions to continue selling the PowerPort without redesigning or adequately warning about the fracture risk.
- PowerPort Evidence and Records — What You Need for Your CaseBuilding a strong PowerPort catheter lawsuit requires gathering specific categories of medical and device records. Even if you no longer have the physical device, documentary evidence of the fracture, fragment location, and resulting injury is sufficient to support a claim.
The full investigation